1. Instituto de Medicina Molecular, Faculdade de Medicina Universidade de Lisboa Lisbon Portugal
2. Department of Pharmacology and Therapeutics, Research Institute of Oncology and Hematology, CancerCare Manitoba University of Manitoba Winnipeg Manitoba Canada
3. VIB Inflammation Research Center Ghent University Ghent Belgium